drugset

drugset / Trial / NCT00000318

Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1

NCT00000318 ↗

Phase 2 Completed 202 enrolled National Institute on Drug Abuse (NIDA) Yale University · collab

RandomizedFactorialOpen-labelTreatment

Summary

The purpose of this study is to assess optimal dosage of buprenorphine on a thrice weekly schedule in a pilot clinical trial.

Timeline

Start: 1994-12
Primary completion: 2004-03
Completion: 2007-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Buprenorphine	Other / unclassified	—	—

Indications